Evaluation of Clinical Efficacy of Tab. AOIM Ã¢â?¬â?? Z in managing after-effects of COVID Ã¢â?¬â?? 19 infection Ã¢â?¬â?? An Open Labelled, Single Arm, Prospective, Exploratory Clinical Study

Shree Dhootapapeshwar Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•Male or Female participants between the age group of 18 to 60 years (both inclusive), Participants with history of positive RT-PCR (Not less than 2 weeks to rule out active infection),3.Participants with symptoms of Post COVID-19 syndrome such as cough, fatigue, shortness of breath, anxiety, olfactory and gustatory dysfunction, Participants who are ready to provide written informed consent and who are ready to voluntarily participate and abide to the protocol requirements

•Pregnant and Lactating females, Participants hospitalized or in institutional quarantine, Participants having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening, Participants having immune compromised status like HIV, Hepatitis, Tuberculosis and Cancer etc., Participants taking steroid treatment and or any kind of immunosuppressive therapy, Participants participating in any other clinical study or having participated in any other study 3 months prior to screening in the present study, Other conditions, which in the opinion of the investigators makes the subject unsuitable for enrolment or could interfere in adherence to of the study protocol

发起方